MLYS
Mineralys Therapeutics, Inc. Common Stock
NASDAQ: MLYS · HEALTHCARE · BIOTECHNOLOGY
$25.56
-1.27% today
Updated 2026-04-29
Market cap
$2.11B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.29
Dividend yield
—
52W range
$13 – $48
Volume
1.2M
Mineralys Therapeutics, Inc. Common Stock (MLYS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-36.90%
ROA
-24.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-3.43M | — | — | — |
| 2021 | $0.00 | $-19.41M | — | — | — |
| 2022 | $0.00 | $-29.80M | — | — | — |
| 2023 | $0.00 | $-71.90M | — | — | — |
| 2024 | $0.00 | $-177.81M | — | — | — |
| 2025 | $0.00 | $-154.65M | — | — | — |